Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | EMP1 |
| Upstream (Parents) |
|---|
| (<<) TNFAIP6 → EMP1 |
| (<<) HBEGF → EMP1 |
| (<<) PLAUR → EMP1 |
| (<<) SLC43A1 → EMP1 |
| Downstream (Children) |
|---|
| EMP1 → ANXA1 (>>) |
| EMP1 → MMP19 (>>) |
| EMP1 → ASAP1IT1 (>>) |
| EMP1 → DCAF15 (>>) |
| EMP1 → KRT17 (>>) |
| EMP1 → TMEM158 (>>) |
| EMP1 → SLC2A3 (>>) |
| EMP1 → AHNAK2 (>>) |
| EMP1 → LPAR3 (>>) |
| EMP1 → C4orf6 (>>) |
| EMP1 → PDGFB (>>) |
| EMP1 → LAMA3 (>>) |
| EMP1 → FBXL18 (>>) |
| EMP1 → DTX3 (>>) |
| EMP1 → SPHK1 (>>) |
| EMP1 → PCSK5 (>>) |
